NO20074086L - Fremgangsmate for fremstilling av lansoprazol - Google Patents

Fremgangsmate for fremstilling av lansoprazol

Info

Publication number
NO20074086L
NO20074086L NO20074086A NO20074086A NO20074086L NO 20074086 L NO20074086 L NO 20074086L NO 20074086 A NO20074086 A NO 20074086A NO 20074086 A NO20074086 A NO 20074086A NO 20074086 L NO20074086 L NO 20074086L
Authority
NO
Norway
Prior art keywords
lansoprazole
preparation
directed
pharmaceutical composition
surface area
Prior art date
Application number
NO20074086A
Other languages
English (en)
Inventor
Franc Vrecer
Berta Kotar-Jordan
Mojca Segula Zakelj
Gregor Ritlop
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20074086L publication Critical patent/NO20074086L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av lansoprazol. Det beskrives videre et lansoprazol med et spesifikt overflateareal, samt et farmasøytisk preparat omfattende lansoprazol.
NO20074086A 2005-01-14 2007-08-07 Fremgangsmate for fremstilling av lansoprazol NO20074086L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05000663A EP1681056A1 (en) 2005-01-14 2005-01-14 Process for preparing lansoprazole
US11/269,211 US7662968B2 (en) 2005-01-14 2005-11-08 Process for preparing lansoprazole
PCT/EP2006/000285 WO2006074952A1 (en) 2005-01-14 2006-01-13 Process for preparing lansoprazole

Publications (1)

Publication Number Publication Date
NO20074086L true NO20074086L (no) 2007-10-10

Family

ID=34933288

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074086A NO20074086L (no) 2005-01-14 2007-08-07 Fremgangsmate for fremstilling av lansoprazol

Country Status (14)

Country Link
US (1) US7662968B2 (no)
EP (3) EP1681056A1 (no)
CN (2) CN101137371B (no)
AT (1) ATE475419T1 (no)
AU (1) AU2006205818A1 (no)
CA (1) CA2594821A1 (no)
DE (1) DE602006015771D1 (no)
EA (1) EA015043B1 (no)
NO (1) NO20074086L (no)
NZ (1) NZ556706A (no)
SI (2) SI1838314T1 (no)
UA (1) UA90293C2 (no)
WO (1) WO2006074952A1 (no)
ZA (1) ZA200706691B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2787378C (en) * 2004-09-13 2015-11-03 Takeda Pharmaceutical Company Limited Method for producing lansoprazole crystal
US8129536B2 (en) 2006-09-22 2012-03-06 Orchid Chemicals & Pharmaceuticals Limited Method for the purification of lansoprazole
ITMI20062481A1 (it) * 2006-12-22 2008-06-23 Recordati Chem Pharm Processo per la preparazione di lansoprazolo forma i microcristallino
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
SI22806A (sl) * 2008-06-23 2009-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalinične oblike natrijevega rabeprazola
CA2781286A1 (en) * 2009-11-20 2011-05-26 Handa Pharmaceuticals, Llc Oral formulation for dexlansoprazole
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN102180865B (zh) * 2011-03-17 2013-01-16 浙江工业大学 一种兰索拉唑的合成方法
CN102558154B (zh) * 2012-02-24 2014-01-08 海南锦瑞制药股份有限公司 一种兰索拉唑结晶化合物及其肠溶胶囊、及制备方法
CN102838537B (zh) * 2012-09-18 2014-04-09 寿光富康制药有限公司 一种兰索拉唑中间体的制备方法
CN103539728A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种拉唑类药物中间体氯甲基吡啶衍生物的合成方法
CN103539729A (zh) * 2013-10-14 2014-01-29 安徽国星生物化学有限公司 一种氯甲基吡啶衍生物的工业化生产方法
CN103664750A (zh) * 2013-12-09 2014-03-26 惠州市莱佛士制药技术有限公司 一种拉唑氯代物的合成方法
CN104083330A (zh) * 2014-02-21 2014-10-08 杭州长典医药科技有限公司 兰索拉唑钠特种超细粉体冻干制剂及其制备方法
CN104447696B (zh) * 2014-11-19 2016-08-17 上海泰坦科技股份有限公司 兰索拉唑的合成工艺
CN104557693B (zh) * 2015-01-16 2017-01-04 江苏中邦制药有限公司 一种3,5-二甲基-4-硝基吡啶-n-氧化物的合成方法
CN104592107B (zh) * 2015-01-16 2017-01-11 江苏中邦制药有限公司 一种2,3-二甲基-4-硝基吡啶-n-氧化物的合成方法
CN104817492B (zh) * 2015-05-22 2018-05-18 抚州三和医药化工有限公司 兰索拉唑中间体2-羟甲基-3-甲基-4-(2,2,2-三氟乙氧基）吡啶的分离纯化方法
CN106928191B (zh) * 2015-12-30 2019-09-03 河南康达制药有限公司 一种兰索拉唑的制备工艺
CN106543146A (zh) * 2016-11-10 2017-03-29 石家庄市度智医药科技有限公司 一种右兰索拉唑的制备方法
CN106749186B (zh) * 2016-12-29 2019-03-05 南京海融制药有限公司 一种右兰索拉唑钠的新晶型及其制备方法
CN106727381B (zh) * 2016-12-29 2020-07-07 南京海融制药有限公司 一种右兰索拉唑钠的口崩片及其制备方法
CN106619520B (zh) * 2016-12-29 2019-08-06 南京海融制药有限公司 一种右兰索拉唑钠的干混悬剂及其制备方法
CN108947967B (zh) * 2018-08-24 2020-10-30 迪嘉药业集团有限公司 一种兰索拉唑的制备方法
CN115715766A (zh) * 2018-09-03 2023-02-28 正大天晴药业集团股份有限公司 包含1,3,5-三嗪衍生物或其盐的固体药物组合物
CN114163419A (zh) * 2021-12-24 2022-03-11 辰欣药业股份有限公司 一种兰索拉唑的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
US6313303B1 (en) * 1997-07-11 2001-11-06 Eisai Co., Ltd. Process for the preparation of pyridine derivatives
NZ516083A (en) * 1999-05-27 2003-08-29 Acusphere Inc Porous drug matrices and methods of manufacture thereof
PL333847A1 (en) * 1999-06-18 2001-01-02 Inst Farmaceutyczny Crystalline forms of lansoprozole and method of obtaining lansoprazole in pharmacologically advanthageous crystalline form
KR20100002278A (ko) * 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
EP1970374A1 (en) * 2001-02-02 2008-09-17 Teva Pharmaceutical Industries Ltd. Process for the production of substituted 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazoles
KR100433735B1 (ko) * 2001-06-27 2004-06-04 주식회사 씨트리 결정형 ⅰ을 갖는 란소프라졸의 제조방법
AU2002321204B2 (en) 2001-07-16 2008-05-08 Janssen Pharmaceutica N.V. Improved process for preparing benzimidazole-type compounds
KR20040093187A (ko) * 2002-03-27 2004-11-04 테바 파마슈티컬 인더스트리즈 리미티드 란소프라졸 다형 및 그것의 제조 방법
JP4115751B2 (ja) * 2002-05-31 2008-07-09 株式会社パーマケム・アジア 微水ベンズイミダゾール系化合物の製法
EP1467987A1 (en) * 2002-07-26 2004-10-20 Teva Pharmaceutical Industries Ltd. Preparation of lansoprazole and related compounds

Also Published As

Publication number Publication date
ATE475419T1 (de) 2010-08-15
CN101137371A (zh) 2008-03-05
EP1838314A1 (en) 2007-10-03
NZ556706A (en) 2009-11-27
EP2308492A1 (en) 2011-04-13
SI1838314T1 (sl) 2010-11-30
CA2594821A1 (en) 2006-07-20
EA015043B1 (ru) 2011-04-29
US20070259049A1 (en) 2007-11-08
EA200701461A1 (ru) 2008-02-28
EP1838314B1 (en) 2010-07-28
WO2006074952A1 (en) 2006-07-20
US7662968B2 (en) 2010-02-16
EP2308492B1 (en) 2016-09-14
CN101824028A (zh) 2010-09-08
AU2006205818A1 (en) 2006-07-20
UA90293C2 (en) 2010-04-26
EP1681056A1 (en) 2006-07-19
DE602006015771D1 (de) 2010-09-09
ZA200706691B (en) 2008-09-25
CN101137371B (zh) 2011-05-25
SI2308492T1 (sl) 2017-02-28

Similar Documents

Publication Publication Date Title
NO20074086L (no) Fremgangsmate for fremstilling av lansoprazol
IL269976B (en) Intermediate compounds for the preparation of quinazolinones as inhibitors of human phophatidylinositol 3-kinase delta
NO20070753L (no) Fremgangsmåte for fremstilling av dihydropteridinoner
NO20076687L (no) Oral doseringsform
HUS1200023I1 (hu) Eljárás vakcinák elõállítására
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
EP1765391A4 (en) BACTERIAL COMPOSITIONS FOR THE TREATMENT OF CANCER
NO20045037D0 (no) Fremgangsmate for fremstilling av atorvastatin-kalsium i amorf form
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
EP1965818A4 (en) WOUND HEALING PROCESS
NO20071299L (no) Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
DE602006004694D1 (de) Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
EA200701306A1 (ru) Лиофилизация виросом
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
EP2083003A4 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLORBUTANE
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ITMO20050001A1 (it) Procedimento per la produzione di oggetti decorativi puzzle.
DE602006018182D1 (de) Verfahren zur herstellung von aralkyloxypyrrolidinderivaten
DE502006008973D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE602006009439D1 (de) Wanderbettverfahrenverfahren zur Herstellung von Phenylalkanen
HU0500145D0 (en) Composition for the treatment of oral diseases
NO20083028L (no) Ny fremgangsmåte for fremstilling av esomeprazol ikke-salt form
DE602006008022D1 (de) Verfahren zur herstellung von duloxetin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application